CDY 7.69% 21.0¢ cellmid limited

News: Cellmid targets substantial sales growth in 2015

  1. A larger product range, increases to its pharmacy distribution and larger salon sales force are expected to deliver substantial sales growth for its consumer health business in 2015. The company is also progressing its lead humanised oncology anti-midkine antibody (CAB102) for use in solid tumours towards the next value inflection point.

 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.015(7.69%)
Mkt cap ! $17.66M
Open High Low Value Volume
19.5¢ 21.5¢ 19.5¢ $48.20K 230.7K

Buyers (Bids)

No. Vol. Price($)
1 2825 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 1692 1
View Market Depth
Last update - 16.10pm 15/02/2019 (20 minute delay) ?
(live)
Last
21.0¢
  Change
0.015 ( 7.69 %)
Open High   Low Volume
21.0¢ 21.0¢   21.0¢ 4838
Last updated 14.51pm 15/02/2019 (live) ?
CDY (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.